NFL suspends former Cal Poly CB Asa Jackson

sports@thetribunenews.comDecember 12, 2012 

Cal Poly's Asa Jackson was taken by the Baltimore Ravens in the fifth round of the NFL Draft.


OWINGS MILLS, Md. — Baltimore Ravens rookie cornerback Asa Jackson, a former Cal Poly football standout, has been suspended for four games for violating the NFL’s policy on performance enhancing substances.

Jackson did not test positive for steroids, according to an anonymous source cited by the Baltimore Sun, but the suspension instead stems from the use of Adderall, a prescription drug often used to treat ADHD.

Jackson just recently earned his first playing time on special teams, appearing in Baltimore’s past three games after being inactive for the first 10. 

A fifth-round pick in the 2012 Draft, Jackson will be suspended without pay. If the Ravens make the playoffs, he will be eligible to return to the active roster the day after the team’s first playoff game.

Jackson is the latest in a string of several suspended players linked to Adderall usage this season. 

A stimulant that was banned by the league in 2006, Adderall has gained popularity on college campuses as a study aid. 

Its effectiveness as a performance enhancer in football has been debated — as has the genuine prevalence in the suspension cases. 

The NFL drug policy prohibits the league from releasing the actual substance a player tests positive for, and many question whether the players who’ve admitted to Adderall use are instead using it as a scapegoat for less socially acceptable PEDs like human growth hormone or steroids.

The Tribune is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service